Experience and Expertise Facilitate Controlled Substance Manufacturing

Read our latest article, as published in the Q1 2017 edition of Pharma's Almanac. 

Screen Shot 2017-03-28 at 3.26.35 PM.pngIntroduction:

Requirements for the manufacture of controlled substances impact all aspects of drug development, manufacturing and distribution. CDMOs that have an in-depth understanding of the regulations, long-standing positive relationships with regulators and a track record of successfully working with controlled substances can accelerate product development and commercialization so that treatments are made available more quickly.

 

Download this Article